Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.2343 per EA under NDC 16729036815. Its NADAC has been published 293 times since Oct 14, 2020.
The Low Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEStrength
25; 40 mg/1; mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729036815
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209281On Market Since
9/3/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 293 times since Oct 14, 2020, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2343 per EA |
|---|---|
| All-time high | $0.8042 (Oct 14, 2020) |
| All-time low | $0.1789 (Nov 20, 2024) |
| 52-week high | $0.2343 |
| 52-week low | $0.2023 |
| Median price | $0.2698 |
| Average price | $0.2791 |
| Largest weekly change | -46.8% (Nov 18, 2020) |
| Weeks tracked | 293 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, manufactured by Accord Healthcare Inc., is $0.2343 per EA (NDC 16729036815), effective May 20, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has declined 70.9%. It has been tracked across 293 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
Since Oct 14, 2020, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has ranged from a low of $0.1789 (Nov 20, 2024) to a high of $0.8042 (Oct 14, 2020), with a median of $0.2698 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, is $0.2317 per EA — about 1% below OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB (NDC 16729036815) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification